(Q44259240)

1 December 2017

title

Anxious-retarded depression: relation with plasma vasopressin and cortisol (English)

1 reference

1 December 2017

0 references

0 references

Remco F P de Winter

1

1 reference

1 December 2017

Albert M van Hemert

2

1 reference

1 December 2017

Roel H DeRijk

3

1 reference

1 December 2017

Koos H Zwinderman

4

1 reference

1 December 2017

Ank C Frankhuijzen-Sierevogel

5

1 reference

1 December 2017

Victor M Wiegant

6

1 reference

1 December 2017

Jaap G Goekoop

7

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

1 December 2017

published in

Neuropsychopharmacology

1 reference

1 December 2017

volume

28

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

140-147

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300002

1 December 2017

exact match

0 references

cites work

Chronic fluoxetine treatment reduces hypothalamic vasopressin secretion in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

Repeated stress enhances vasopressin synthesis in corticotropin releasing factor neurons in the paraventricular nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

Multidimensional ordering of psychopathology. A factor-analytic study using the Comprehensive Psychopathological Rating Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

The interrater reliability of a Dutch version of the Comprehensive Psychopathological Rating Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

Multidimensional hierarchic ordering of psychopathology. Rasch analysis in factor-analytic dimensions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

Arginine vasopressin is associated with hypercortisolemia and suicide attempts in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

Corticotropin-releasing factor-immunoreactive neurons of the paraventricular nucleus become vasopressin positive after adrenalectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

DST studies in psychotic depression: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

Subtyping depression by clinical features: the Australasian database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

Antipsychotic drugs and plasma vasopressin in normals and acute schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

Melancholic symptom features and DSM-IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

Hypercortisolism and its possible neural bases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

Release of corticotropin after administration of corticotropin-releasing hormone in depressed patients in relation to the dexamethasone suppression test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

Effect of metyrapone on the pituitary-adrenal axis in depression: relation to dexamethasone suppressor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

Plasma levels of arginine vasopressin elevated in patients with major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

Alcohol consumption and major depression: findings from a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

Comparative study of the effect of oral contraceptives containing 50 microgram of estrogen and those containing 20 microgram of estrogen on adrenal cortical function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

7 January 2021

A comprehensive psychopathological rating scale

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

7 January 2021

Cerebrospinal fluid and plasma free cortisol concentrations in depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

7 January 2021

A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

7 January 2021

Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

7 January 2021

Stimulation of vasopressin release in women with primary dysmenorrhoea and after oral contraceptive treatment--effect on uterine contractility

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

7 January 2021

Increased CSF cortisol levels after neuroleptic treatment in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

7 January 2021

Endogenous vasopressin contributes to hypothalamic-pituitary-adrenocortical alterations in aged rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

7 January 2021

Neurohypophysial hormone and melatonin secretion over the natural and suppressed menstrual cycle in premenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

7 January 2021

Glucocorticoid negative feedback selectively targets vasopressin transcription in parvocellular neurosecretory neurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

7 January 2021

Evidence for the existence of major depression with and without anxiety features

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

7 January 2021

Corticosteroid receptor function is decreased in depressed patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

7 January 2021

Selective activation of the hypothalamic vasopressinergic system in mice deficient for the corticotropin-releasing hormone receptor 1 is dependent on glucocorticoids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

7 January 2021

Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

7 January 2021

Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

7 January 2021

The dexamethasone suppression test in patients with mood disorders.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

7 January 2021

De Widlöcher Remmingsschaal, een Nederlandse Schaal Voor het Meten van Psychomotorische Remming

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300002

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300002

1 reference

1 December 2017

1 reference